RecruitingPhase 1Phase 2NCT06545890

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries: A Randomized Controlled Study.

Sponsor

Cairo University

Enrollment

46 participants

Start Date

Aug 10, 2024

Study Type

INTERVENTIONAL

Conditions

Emergence Delirium

Summary

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.

Eligibility

Min Age: 2 YearsMax Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexmedetomidine and a drug called Ketamine for people with emergence delirium. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 2 Years to 6 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

continous infusion during surgery

DRUGDexmedetomidine

continous infusion during surgery

Locations(2)

Abu Elresh Hospitals ( Cairo university )

Cairo, Egypt

Abu ElResh hospital

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06545890

Related Trials

Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery.

NCT074356751 location

Language During Inhalational Induction

NCT063249551 location